Enlivex Therapeutics Ltd. buy melinda
Start price
26.09.17
/
50%
€14.65
Target price
28.09.17
€18.04
Performance (%)
13.71%
End price
28.09.17
€16.66
Summary
This prediction ended on 28.09.17 with a price of €16.66. The BUY prediction by melinda finished with a performance of 13.71%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | 3.390% | 3.390% | -3.684% | -74.668% |
| iShares Core DAX® | 1,23 % | 1,50 % | 11,29 % | 63,49 % |
| iShares Nasdaq 100 | 0,69 % | -1,95 % | 5,59 % | 88,83 % |
| iShares Nikkei 225® | 2,08 % | 11,06 % | 31,15 % | 67,95 % |
| iShares S&P 500 | 0,42 % | 0,21 % | 4,12 % | 60,99 % |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Phase LE2 / 02/2017
zu folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€21.20
25.10.17
25.10.17
€22.40
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€47.63
27.01.17
27.01.17
€72.16
27.07.17
27.07.17
-53.77%
27.07.17
27.07.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16